--- title: "NHS Framework for the supply of Licensed Antiretroviral Therapy (ART) for the treatment of HIV (Lot 1) & provision of a service to supply over labelled PrEP and PEP packs (Lot 2) 1 November 2024" ocid: "ocds-h6vhtk-044a0a" canonical_url: "https://d3tenders.com/contract/?ocid=ocds-h6vhtk-044a0a" markdown_url: "https://d3tenders.com/contract/ocds-h6vhtk-044a0a.md" json_url: "https://d3tenders.com/contract/ocds-h6vhtk-044a0a.json" source: "Find A Tender Service" current_stage: "Award" buyer: "NHS ENGLAND" published: "2024-11-28" --- # NHS Framework for the supply of Licensed Antiretroviral Therapy (ART) for the treatment of HIV (Lot 1) & provision of a service to supply over labelled PrEP and PEP packs (Lot 2) 1 November 2024 Buyer: NHS ENGLAND Current stage: Award OCID: ocds-h6vhtk-044a0a [View canonical contract page](https://d3tenders.com/contract/?ocid=ocds-h6vhtk-044a0a) [Download OCDS JSON](https://d3tenders.com/contract/ocds-h6vhtk-044a0a.json) ## Summary NHS England has completed an open procedure tender for a framework agreement concerning the supply of Licensed Antiretroviral Therapy (ART) for the treatment of HIV (Lot 1), and the provision of a service to supply over labelled Pre-Exposure Prophylaxis (PrEP) and Post-Exposure Prophylaxis (PEP) packs (Lot 2). The procurement falls under the pharmaceutical products category (CPV: 33600000) with the main procurement category being goods. The framework agreement runs from 1st November 2024 to 31st October 2026, with an optional extension of up to 24 months. This national-level procurement covers the entire United Kingdom, with a framework value of £1.08 billion, indicating significant opportunities for suppliers. The contracts were awarded on 28th October 2024, with several suppliers including Gilead Sciences Ltd, ViiV Healthcare UK Ltd, and others being selected. This tender offers substantial growth opportunities for businesses supplying pharmaceutical products, particularly those specialising in HIV treatments and prevention solutions. Both large-scale enterprises and SMEs stand a chance to benefit, given the considerable framework value and the potential for an extension. Businesses that can provide competitive pricing and meet the stringent supply and service criteria set by NHS England would be well-positioned to compete. The involvement of various well-known pharmaceutical companies highlights the high standards and the significant market impact of participating in this procurement process. ## Notice Project title: NHS Framework for the supply of Licensed Antiretroviral Therapy (ART) for the treatment of HIV (Lot 1) & For the provision of a service to supply over labelled Pre-Exposure Prophylaxis (PrEP) and Post-Exposure Prophylaxis (PEP) Packs for the prevention of HIV (Lot 2) 1st November 2024 Offer reference number: CM/PHS/24/5709 Period of framework agreement: 1st November 2024 to 31st October 2026 with an option to extend (at the Authority's discretion) for a further period (or periods) up to a total of 24 months ### Lot Information Lot 1 Project title: NHS Framework for the supply of Licensed Antiretroviral Therapy (ART) for the treatment of HIV (Lot 1) & For the provision of a service to supply over labelled Pre-Exposure Prophylaxis (PrEP) and Post-Exposure Prophylaxis (PEP) Packs for the prevention of HIV (Lot 2) 1st November 2024 Offer reference number: CM/PHS/24/5709 Period of framework agreement: 1st November 2024 to 31st October 2026 with an option to extend (at the Authority's discretion) for a further period (or periods) up to a total of 24 months. Additional information: Price is not the only award criterion and all criteria are stated only in the procurement documents. Options: option to extend (at the Authority's discretion) for a further period (or periods) up to a total of 24 ## Key Details | Field | Value | | --- | --- | | Publication source | Find A Tender Service | | Latest notice | https://www.find-tender.service.gov.uk/Notice/038398-2024 | | Notice type | Tender Notice | | Procurement type | Framework | | Procurement category | Goods | | Procurement method | Open | | Procurement method details | Open procedure | | Tender suitability | Not specified | | Awardee scale | Large, SME | | All stages | Tender, Award | ## Dates | Field | Value | | --- | --- | | Publication date | 28 Nov 2024 | | Submission deadline | 22 Apr 2024 | | Future notice date | Not specified | | Award date | 28 Oct 2024 | | Contract period | 1 Nov 2024 - 31 Oct 2026 | | Recurrence | Not specified | ## Values | Field | Value | | --- | --- | | Tender value | £1,080,000,000 | | Lots value | £1,080,000,000 | | Awards value | Not specified | | Contracts value | £1 | ## Status | Field | Value | | --- | --- | | Tender status | Complete | | Lots status | Cancelled | | Awards status | Active | | Contracts status | Active | ## Buyer | Field | Value | | --- | --- | | Main buyer | NHS ENGLAND | | Locality | LEEDS | | Post town | Leeds | | Postcode | LS2 7UE | | Country | England | | ITL 1 | TLI London | | ITL 2 | TLI4 Inner London - East | | ITL 3 | TLI45 Lambeth | | Local authority | Lambeth | | Electoral ward | Waterloo & South Bank | | Westminster constituency | Vauxhall and Camberwell Green | | Delivery location | Not specified | ## Supplier | Field | Value | | --- | --- | | Number of suppliers | 13 | | Supplier names | ABBVIE; AMAROX; DR.REDDY'S LABORATORIES (UK; GILEAD SCIENCES; JANSSEN-CILAG; LUPIN HEALTHCARE (UK; MACLEODS PHARMA; MAWDSLEY-BROOKS AND; MERCK SHARP AND DOHME (UK; MILPHARM LTD/AUROBINBDO; MSN LABORATORIES EUROPE; MYLAN UK HEALTHCARE; VIIV HEALTHCARE | ## CPV Codes ### Divisions - 33 - Medical equipments, pharmaceuticals and personal care products ### Codes - 33600000 - Pharmaceutical products ## Release History - 28 Nov 2024 at 10:05 - Award - Award Notice - https://www.find-tender.service.gov.uk/Notice/038398-2024 - 19 Apr 2024 at 13:43 - TenderUpdate - Tender Notice - https://www.find-tender.service.gov.uk/Notice/012837-2024 - 18 Mar 2024 at 16:45 - Tender - Tender Notice - https://www.find-tender.service.gov.uk/Notice/008717-2024 ## Notice URLs - http://gilead.com - http://health.atamis.co.uk - http://www.abbvie.co.uk - http://www.amaroxpharma.co.uk - http://www.jnj.com - http://www.macleodspharma.com - http://www.mawdsleys.co.uk - http://www.msd-uk.com - http://www.mylan.co.uk/ - http://www.viivhealthcare.com - https://health-family.force.com/s/Welcome - https://supplierregistration.cabinetoffice.gov.uk - https://www.drreddys.com/ - https://www.england.nhs.uk/ - https://www.england.nhs.uk// - https://www.judiciary.uk/courts-and-tribunals/high-court/ - https://www.lupinhealthcare.co.uk ## Provenance This Markdown file is an alternate public rendering of the D3 Tenders contract record. The canonical page is https://d3tenders.com/contract/?ocid=ocds-h6vhtk-044a0a. The underlying structured data is available as OCDS JSON at https://d3tenders.com/contract/ocds-h6vhtk-044a0a.json.